UNSPSC 51203605: Teriflunomide

This classification denotes an enzyme inhibitor with the molecular formula C12H9F3N2O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier (SRS UNII) 1C058IKG3B, chemically known as 2-butenamide, 2-cyano-3-hydroxy-n-(4-(trifluoromethyl)phenyl)- but more generally known as teriflunomide, which bears US NIH Compound Identifier 5479847. European Medicines Agency schedules Teriflunomide in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB25218.

UNSPSC 51203605 Teriflunomide, a Commodity code, does not align with the recent state and local procurement activity posted under this classification. The four recent opportunities recovered under the code involve naloxone and drug deactivation systems (Seminole County, Florida), direct-to-manufacturer prescription programs (Texas HHS Commission), emergency medical and first aid supplies (City of Tampa), and generic pharmaceuticals distributed through cooperative purchasing (Minnesota Multistate Cooperative Purchasing Alliance). None of these solicitations concern teriflunomide, a disease-modifying antirheumatic drug used to treat multiple sclerosis. The code appears to carry little or no relevant recent activity at the state and local level.

The mismatch between the code's nominal scope and the actual opportunities suggests either a cataloging error in the underlying procurement system or a code that does not reflect current state and local purchasing patterns. Business development professionals should verify the intended UNSPSC classification before investing resources in this code. If teriflunomide procurement is a stated objective, direct engagement with state Medicaid agencies, health and human services departments, and healthcare cooperative purchasing organizations would yield more actionable intelligence than monitoring this code classification.